Mark P. Epping-Jordan

2.0k total citations · 1 hit paper
11 papers, 1.6k citations indexed

About

Mark P. Epping-Jordan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Mark P. Epping-Jordan has authored 11 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Mark P. Epping-Jordan's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Mark P. Epping-Jordan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Mark P. Epping-Jordan collaborates with scholars based in United States, Italy and France. Mark P. Epping-Jordan's co-authors include Athina Markou, George F. Koob, George F. Koob, Francesco Orzi, Stefano Tacconi, Cristiano Chiamulera, Alessandro Zocchi, M. Corsi, Clara Marcon and François Conquet and has published in prestigious journals such as Nature, Nature Neuroscience and Brain Research.

In The Last Decade

Mark P. Epping-Jordan

11 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dramatic decreases in brain reward function during nicotine withdrawal

1998 542 citations Mark P. Epping-Jordan, George F. Koob et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark P. Epping-Jordan United States	9	1.2k	1.0k	314	193	109	11	1.6k
Alexis Evrard France	15	1.1k 0.9×	1.0k 1.0×	185 0.6×	222 1.2×	136 1.2×	21	1.6k
Randal S. Revay United States	10	1.3k 1.1×	898 0.9×	236 0.8×	188 1.0×	108 1.0×	12	1.7k
Anna Molander Sweden	17	991 0.8×	605 0.6×	187 0.6×	197 1.0×	78 0.7×	21	1.4k
G. Godeheu France	24	1.7k 1.4×	1.0k 1.0×	219 0.7×	289 1.5×	141 1.3×	39	2.1k
Manolo Mugnaini Italy	19	996 0.8×	881 0.8×	135 0.4×	164 0.8×	64 0.6×	28	1.4k
Valérie Compan France	21	853 0.7×	539 0.5×	180 0.6×	210 1.1×	102 0.9×	39	1.4k
M. Teresa Vilaró Spain	28	1.8k 1.6×	1.5k 1.4×	166 0.5×	314 1.6×	126 1.2×	44	2.4k
Jesse Brodkin United States	18	1.4k 1.2×	1.0k 1.0×	163 0.5×	232 1.2×	132 1.2×	20	1.9k
Emmanuel Darcq France	26	1.3k 1.1×	1.0k 1.0×	346 1.1×	302 1.6×	119 1.1×	62	2.0k
François Hogenboom Netherlands	24	1.8k 1.6×	1.3k 1.2×	398 1.3×	275 1.4×	191 1.8×	38	2.2k

Countries citing papers authored by Mark P. Epping-Jordan

Since Specialization

Citations

This map shows the geographic impact of Mark P. Epping-Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Epping-Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Epping-Jordan more than expected).

Fields of papers citing papers by Mark P. Epping-Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Epping-Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Epping-Jordan. The network helps show where Mark P. Epping-Jordan may publish in the future.

Co-authorship network of co-authors of Mark P. Epping-Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Epping-Jordan. A scholar is included among the top collaborators of Mark P. Epping-Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Epping-Jordan. Mark P. Epping-Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Epping-Jordan, Mark P., Françoise Girard, Anne‐Sophie Bessis, et al.. (2023). Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson’s Disease. Cells. 12(7). 1004–1004. 7 indexed citations

King, Madeleine V., Nisha Kurian, Si Qin, et al.. (2013). Lentiviral Delivery of a Vesicular Glutamate Transporter 1 (VGLUT1)-Targeting Short Hairpin RNA Vector Into the Mouse Hippocampus Impairs Cognition. Neuropsychopharmacology. 39(2). 464–476. 13 indexed citations

Rocher, Jean‐Philippe, Béatrice Bonnet, Christelle Boléa, et al.. (2011). mGluR5 Negative Allosteric Modulators Overview: A Medicinal Chemistry Approach Towards a Series of Novel Therapeutic Agents. Current Topics in Medicinal Chemistry. 11(6). 680–695. 46 indexed citations

Chiamulera, Cristiano, Mark P. Epping-Jordan, Alessandro Zocchi, et al.. (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neuroscience. 4(9). 873–874. 459 indexed citations

Damaj, M. Imad, et al.. (2001). Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice. Nature Neuroscience. 4(4). 357–358. 93 indexed citations

Salmon, A.-M., Imad Damaj, Lisa M. Marubio, et al.. (2001). Altered Neuroadaptation in Opiate Dependence and Neurogenic Inflammatory Nociception in αCGRP Deficient Mice. The Scientific World JOURNAL. 1. 22–22. 3 indexed citations

Epping-Jordan, Mark P., Marina R. Picciotto, Jean‐Pierre Changeux, & Emilio Merlo Pich. (1999). Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology. 147(1). 25–26. 69 indexed citations

Epping-Jordan, Mark P., et al.. (1999). Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats. Pharmacology Biochemistry and Behavior. 62(4). 743–751. 194 indexed citations

Pich, Emilio Merlo & Mark P. Epping-Jordan. (1998). Transgenic mice in drug dependence research. Annals of Medicine. 30(4). 390–396. 26 indexed citations

10.

Epping-Jordan, Mark P., A. Markou, & George F. Koob. (1998). The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Research. 784(1-2). 105–115. 99 indexed citations

11.

Epping-Jordan, Mark P., et al.. (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 393(6680). 76–79. 542 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact